Objective: To evaluate the benefits of functional constipation (FC) management in male patients with male lower urinary tract symptoms (LUTS) coexisting with FC. Materials and Methods: We conducted a prospective study including 1748 men over the age of 40 who were admitted to our clinic with newly diagnosed male LUTS. The patients were evaluated by history, International Prostate Symptom Score (IPSS), uroflowmetry, urinalysis, serum prostate-specific antigen testing, measurement of prostate volume by ultrasonography and post-void residual urine volume. Rectal fleet enema was administered in patients with FC diagnosed according to the Rome III criteria. Uroflowmetry tests were repeated 12 hours after enema. The patients were re-evaluated after treatment with oral sennoside once a day for a month. Results: At the end of the 1 st month, 62 patients with male LUTS and FC were re-evaluated. The difference between maximum flow rate Qmax values before the treatment of constipation and in the 1 st month after the treatment was statistically significant (p
Amaç: Alt üriner sistem semptomları (AÜSS) ve eşzamanlı fonksiyonel kabızlığı (FK) olan erkeklerde fonksiyonel kabızlığı tedavi etmenin faydalarını değerlendirmektir. Gereç ve Yöntem: Yeni tanı alan AÜSS ile kliniğimize başvuran 40 yaş üzeri 1748 erkek hasta prospektif olarak çalışmaya dahil edildi. Hastalar; özgeçmiş, IPSS, üroflovmetri, idrar analizi, serum prostat spesifik antijen tayini, üriner sistem ultrasonografisi yardımı ile prostat hacmi ve işeme sonrası artık idrar volümü ölçümü ile değerlendirildi. Roma III kriterlerine göre tanı konan FK hastalarına rektal lavman uygulandı. Hastalar bir ay boyunca günde bir kez oral sennoside ile tedaviden sonra tekrar değerlendirildi. Bulgular: Birinci ayın sonunda erkek alt üriner sistem şikayetleri ve FK olan 62 hasta yeniden değerlendirildi. Kabızlık tedavisinden önceki ve tedaviden sonra 1. aydaki Qmax değerleri arasındaki fark istatistiksel olarak anlamlıydı (p
1. Speakman M, Kirby R, Doyle S, Ioannou C. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK. BJU Int 2015;115:508-519.
2. C Coyne KS, Kaplan SA, Chapple CR, Sexton CC, Kopp ZS, Bush EN, Aiyer LP; EpiLUTS Team. Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS. BJU Int 2009;103:24-32.
3. McGrath KH, Caldwell PH, Jones MP. The frequency of constipation in children with nocturnal enuresis: a comparison with parental reporting. J Paediatr Child Health 2008;44:19-27.
4. Carter D, Beer-Gabel M. Lower urinary tract symptoms in chronically constipated women. Int Urogynecol J 2012;23:1785-1789.
5. Chrzan R, Klijn AJ, Vijverberg MA, Sikkel F, de Jong TP. Colonic washout enemas for persistent constipation in children with recurrent urinary tract infections based on dysfunctional voiding. Urology 2008;71:607-610.
6. Loening-Baucke V. Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood. Pediatrics 1997;100:228-232.
7. Soligo M, Salvatore S, Emmanuel AV, De Ponti E, Zoccatelli M, Cortese M, Milani R. Patterns of constipation in urogynecology: clinical importance and pathophysiologic insights. Am J Obstet Gynecol 2006;195:50-55.
8. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-1491.
9. Charach G, Greenstein A, Rabinovich P, Groskopf I, Weintraub M. Alleviating constipation in the elderly improves lower urinary tract symptoms. Gerontology 2001;47:72-76.
10. Mearin F, Lacy BE. Diagnostic criteria in IBS: useful or not? Neurogastroenterol Motil 2012;24:791-801.
11. Burgers RE, Mugie SM, Chase J, Cooper CS, von Gontard A, Rittig CS, Homsy Y, Bauer SB, Benninga MA. Management of functional constipation in children with lower urinary tract symptoms: report from the Standardization Committee of the International Children’s Continence Society. J Urol 2013;190:29-36.
12. Koskimäki J, Hakama M, Huhtala H, Tammela TL. Association of nonurological diseases with lower urinary tract symptoms. Scand J Urol Nephrol 2001;35:377-381.
13. Kaplan SA, Dmochowski R, Cash BD, Kopp ZS, Berriman SJ, Khullar V. Systematic review of the relationship between bladder and bowel function: implications for patient management. Int J Clin Pract 2013;67:205-216.
14. Zantl N, Hartung R. TUR-Related Complications. In: Hohenfellner M, Santucci RA editors. Emergencies in Urology. Berlin: Springer, 2007:335- 348.
15. Rieken M, Ebinger Mundorff N, Bonkat G, Wyler S, Bachmann A. Complications of laser prostatectomy: a review of recent data. World J Urol 2010;28:53-62.
16. Nickel JC. BPH: costs and treatment outcomes. Am J Manag Care 2006;12:141-148.
17. Gacci M, Corona G, Vignozzi L, Salvi M, Serni S, De Nunzio C, Tubaro A, Oelke M, Carini M, Maggi M. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. BJU Int 2015;115:24- 31.
18. Averbeck MA, Madersbacher H. Constipation and LUTS - how do they affect each other? Int Braz J Urol 2011;37:16-28.
19. Chase JW, Homsy Y, Siggaard C, Sit F, Bower WF. Functional constipation in children. J Urol 2004;171:2641-2643.
20. Saga S, Vinsnes AG, Mørkved S, Norton C, Seim A. What characteristics predispose to continence in nursing home residents?: a population-based cross-sectional study. Neurourol Urodyn 2015;34:362-367.